In the field of IVD (in vitro diagnostics), the success of a product often depends on three core elements: cost, menu, and turnaround time. Among them, cost determines the market competitiveness of the product, menu determines the breadth of product application, and turnover time is directly related to user experience and clinical efficiency. Today, we will take Cubit as an example to explore how an IVD product can achieve breakthroughs in cost and menu design, and stand out in fierce market competition.

Low cost: comprehensive optimization from reagents to equipment

Cost control is one of the key factors for the success of IVD products. Cubit has demonstrated excellent capabilities in cost control. According to data from the Biomedical Research and Development Authority (BARDA) seminar in November last year, Cubit's molecular testing costs less than 40 yuan ($5) per box, and its immunological testing costs less than 16 yuan ($2) per box. This price has significant competitiveness in many medical fields.

In addition to the low cost of reagents, Cubit also further reduces costs by optimizing the storage conditions of reagents. Its reagents can be stored at room temperature, which not only reduces the cost of cold chain transportation and storage, but also provides greater convenience for customers. However, the cost of reagents is only a part of the cost of IVD products. Equipment cost is also an important factor that cannot be ignored.

Multi menu: Full coverage from respiratory detection to sexually transmitted infections

The diversity of menus is another important competitive advantage of IVD products. Cubit company started with the current popular respiratory testing track and developed a triple detection system for both H1N1 and H1N1 influenza. This product not only meets the market's demand for fast and accurate detection, but also improves efficiency through multi link detection.

In addition to respiratory detection, Cubit is also developing sexually transmitted infection tests for chlamydia, gonorrhoea and trichomoniasis resistance, as well as tuberculosis tests and high-risk screening tests for HIV, hepatitis C virus and hepatitis B virus. In addition, the company also plans to expand its testing menu through collaboration, adding more immunoassays as well as testing for streptococci and urinary tract infections. This diversified menu design enables Cubit to meet diverse needs in different medical scenarios.

To win the market, one must also be able to defend the city

In the field of IVD, low cost and multiple menus are the key paths to product success. Cubit has successfully gained a foothold in the fierce market competition by optimizing reagent and equipment costs, expanding its detection menu. However, the success of a product not only depends on technology and cost control, but also requires comprehensive layout in market access, patent layout, and business model.

Registration and listing is a necessary path for IVD products to enter a larger market, patent layout is an important means of technical protection, and the construction of a business model is the key to long-term success of the product. In the field of IVD, low cost and multiple menus are the key paths to product success. Cubit has successfully gained a foothold in the fierce market competition by optimizing reagent and equipment costs, expanding its detection menu. However, the success of a product not only depends on technology and cost control, but also requires comprehensive layout in market access, patent layout, and business model.

In the development process of IVD products, in addition to cost and menu design, the selection of raw materials is also crucial. As an important partner in the IVD industry, Desheng New Materials will continue to focus on the research and production of biological buffering agents, chemiluminescence reagents, and color reagents, committed to providing high-quality and stable IVD products for the IVD industry. To assist IVD enterprises in achieving greater success in technology research and market expansion.